Opexa Therapeutics OPXA today announced the pricing of an
underwritten public offering of 4.12 million shares of its common stock
at a price to the public of $1.70 per share. The gross proceeds to Opexa
from this offering are expected to be approximately $7 million, before
deducting underwriting discounts and commissions and other estimated
offering expenses. All of the shares in the offering are to be sold by
Opexa. Opexa has also granted the underwriters a 45-day option to
purchase up to an additional 618,000 shares of common stock to cover
over-allotments, if any. The offering is expected to close on or about
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in